PAA 2.27% 22.5¢ pharmaust limited

Pitt St Research Presentation by Dr Richard Mollard 28/11/2019, page-5

  1. 2,387 Posts.
    lightbulb Created with Sketch. 1473
    You've now got 4 top class independent institutions participating in the trial. And so far, contrary to the usual rumour mongering of down rampers taking advantage of those who have not followed the details of this story carefully the last few years, nothing, absolutely nothing points to issues at this stage; everything is just panning out pretty much as anticipated except for the slippage of the hoped for schedule, which is usual with these things we're everything has to be done according to the book. If this keeps up, and the impressive science behind it suggests no reason why it shouldn't, there's going to be a lot of people moaning at missing out when this takes off unexpectedly.

    You're absolutely right about their marketing however. Great scientists and experienced corporate warriors but not so good at promotion and managing unrealistic time expectations of investors (though they have improved a lot lately).
    Last edited by Lastly: 13/12/19
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $100.1M
Open High Low Value Volume
22.0¢ 22.5¢ 21.5¢ $194.1K 889.8K

Buyers (Bids)

No. Vol. Price($)
2 4996 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 114999 4
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.